Literature DB >> 10462324

Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.

W C Chan1.   

Abstract

The lymphocyte-predominant (LP) type of Hodgkin's lymphoma (HL) is a unique subtype with characteristic tumor cells (lymphocytic and/or histiocytic [L&H] cells) in associated macronodular structures that resemble progressively transformed germinal centers (PTGCs). Immunohistochemical studies have provided strong evidence that L&H cells are of B-cell lineage and recent molecular studies suggested they are transformed centroblasts. A major clonal population is detectable at presentation, with the immunoglobulin heavy-chain gene often showing evidence of continued somatic hypermutation. In developed nations, Epstein-Barr virus (EBV) is infrequently associated with L&H cells and is probably not involved in the pathogenesis of this disease. L&H cells are frequently surrounded by CD3+, CD4+, CD57+, and CD40L- T cells, but the significance of this T-cell rosetting is unclear. LPHL may be associated with concurrent or subsequent large B-cell lymphoma, and there is evidence of a clonal relationship between the two entities. LPHL may also have nodules or large areas that resemble histiocyte-rich B-cell lymphoma (HRBCL). It is likely that at least some cases of HRBCL arise from LPHL. The same may be true of T-cell-rich B-cell lymphoma. Little is known about cytogenetic abnormalities, the cytokine expression profile, and the expression of several functionally important molecules that have been demonstrated in the Reed-Sternberg (RS) cells of classical HL. The challenge for the future is to obtain a more comprehensive molecular profile of L&H cells and their associated T lymphocytes, so as to provide a framework for eventual elucidation of the pathogenesis of this type of HL.

Entities:  

Mesh:

Year:  1999        PMID: 10462324

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  7 in total

1.  Expression profiling of human tumors: the end of surgical pathology?

Authors:  M Ladanyi; W C Chan; T J Triche; W L Gerald
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

2.  Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments.

Authors:  Cigdem Atayar; Anke van den Berg; Tjasso Blokzijl; Marcel Boot; Randy D Gascoyne; Lydia Visser; Sibrand Poppema
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

Review 3.  Lymphocyte predominant Hodgkin's disease.

Authors:  Bradley C Ekstrand; Sandra J Horning
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 4.  Pitfalls in diagnostic hematopathology -- Part II.

Authors:  Xianfeng F Zhao
Journal:  Int J Clin Exp Pathol       Date:  2009-09-10

Review 5.  Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

Authors:  G Kapatai; P Murray
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

6.  Hodgkin lymphoma: flow me?

Authors:  Michael W Beaty; Kim R Geisinger
Journal:  Cytojournal       Date:  2005-09-08       Impact factor: 2.091

7.  Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma.

Authors:  Hyung-Chul Park; Sung-Hoon Jung; Jae-Sook Ahn; Mi-Young Kim; Deok-Hwan Yang; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.